Jane Street Group LLC Has $1.81 Million Position in MiMedx Group, Inc. (NASDAQ:MDXG)

Jane Street Group LLC lifted its holdings in MiMedx Group, Inc. (NASDAQ:MDXG) by 133.6% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 305,652 shares of the company’s stock after acquiring an additional 174,797 shares during the quarter. Jane Street Group LLC’s holdings in MiMedx Group were worth $1,806,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Allspring Global Investments Holdings LLC boosted its position in MiMedx Group by 1.0% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 183,021 shares of the company’s stock worth $1,082,000 after acquiring an additional 1,822 shares during the period. Hsbc Holdings PLC boosted its holdings in shares of MiMedx Group by 7.3% during the second quarter. Hsbc Holdings PLC now owns 34,343 shares of the company’s stock worth $233,000 after purchasing an additional 2,329 shares during the period. The Manufacturers Life Insurance Company grew its position in MiMedx Group by 7.6% during the second quarter. The Manufacturers Life Insurance Company now owns 45,623 shares of the company’s stock valued at $316,000 after purchasing an additional 3,222 shares in the last quarter. Marshall Wace LLP increased its stake in MiMedx Group by 1.1% in the 2nd quarter. Marshall Wace LLP now owns 298,818 shares of the company’s stock valued at $2,071,000 after buying an additional 3,223 shares during the period. Finally, Principal Financial Group Inc. lifted its position in MiMedx Group by 6.3% in the 3rd quarter. Principal Financial Group Inc. now owns 55,495 shares of the company’s stock worth $328,000 after buying an additional 3,292 shares in the last quarter. Institutional investors and hedge funds own 79.15% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded shares of MiMedx Group from a “strong-buy” rating to a “buy” rating in a research note on Friday, November 8th. Six research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $12.00.

MiMedx Group Stock Performance

MDXG stock opened at $9.13 on Thursday. The firm has a 50 day moving average of $8.21 and a two-hundred day moving average of $7.13. MiMedx Group, Inc. has a 12 month low of $5.47 and a 12 month high of $10.14. The company has a market capitalization of $1.34 billion, a price-to-earnings ratio of 16.60 and a beta of 1.97. The company has a quick ratio of 3.53, a current ratio of 4.10 and a debt-to-equity ratio of 0.10.

MiMedx Group Company Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.